Company intelligence / Profile preview

Kyowa Pharma Chemical

Ownership: Private
Employees: ~530
Development stage: Other

Overview

Kyowa Pharma Chemical is a prominent Japanese CDMO and manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Following its acquisition by Advent International from Kyowa Kirin in 2024, the company continues to provide contract development and manufacturing services for global pharmaceutical companies, specializing in high-quality organic synthesis and GMP-compliant production.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Kyowa KirinAdvent International

Beyond the preview

Go deeper on Kyowa Pharma Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kyowa Pharma Chemical.